SPBP Is a Phosphoserine-Specific Repressor of Estrogen Receptor α

REFERENCES

• Ali, S., D. Metzger, J. M. Bornert, and P. Chambon. 1993. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12:1153–1160.
   PubMed Web of Science ®Google Scholar
• Bunone, G., P.-A. Briand, R. J. Miksicek, and D. Picard. 1996. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:2174–2183.
   PubMed Web of Science ®Google Scholar
• Campbell, R. A., P. Bhat-Nakshatri, N. M. Patel, D. Constantinidou, S. Ali, and H. Nakshatri. 2001. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: a new model for anti-estrogen resistance. J. Biol. Chem. 276:9817–9824.
   PubMed Web of Science ®Google Scholar
• Cenni, B., and D. Picard. 1999. Ligand-independent activation of steroid receptors: new roles for old players. Trends Endocrinol. Metab. 10:41–46.
   PubMedGoogle Scholar
• Chen, D., T. Riedl, E. Washbrook, P. E. Pace, R. C. Coombes, J. M. Egly, and S. Ali. 2000. Activation of estrogen receptor α by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 6:127–137.
   PubMed Web of Science ®Google Scholar
• Chen, D., E. Washbrook, N. Sarwar, G. J. Bates, P. E. Pace, V. Thirunuvakkarasu, J. Taylor, R. J. Epstein, F. V. Fuller-Pace, J. M. Egly, R. C. Coombes, and S. Ali. 2002. Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 21:4921–4931.
   PubMed Web of Science ®Google Scholar
• Ciana, P., M. Raviscioni, P. Mussi, E. Vegeto, I. Que, M. G. Parker, C. Lowik, and A. Maggi. 2003. In vivo imaging of transcriptionally active estrogen receptors. Nat. Med. 9:82–86.
   PubMed Web of Science ®Google Scholar
• Clark, D. E., C. E. Poteet-Smith, J. A. Smith, and D. A. Lannigan. 2001. Rsk2 allosterically activates estrogen receptor α by docking to the hormone-binding domain. EMBO J. 20:3484–3494.
   PubMed Web of Science ®Google Scholar
• Daro, E., P. Van der Sluijs, T. Galli, and I. Mellman. 1996. Rab4 and cellubrevin define different early endosome populations on the pathway of transferrin receptor recycling. Proc. Natl. Acad. Sci. USA 93:9559–9564.
   PubMed Web of Science ®Google Scholar
• Deblois, G., and V. Giguère. 2003. Ligand-independent coactivation of ERα AF-1 by steroid receptor RNA activator (SRA) via MAPK activation. J. Steroid Biochem. Mol. Biol. 85:123–131.
   PubMedGoogle Scholar
• Donzé, O., T. Abbas-Terki, and D. Picard. 2001. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 20:3771–3780.
   PubMed Web of Science ®Google Scholar
• Donzé, O., P. Dudek, and D. Picard. 2004. siRNA production by in vitro transcription, p. 59–72. In M. Sohail (ed.), Gene silencing by RNA interference: technology and application. CRC Press LLC, Boca Raton, Fla.
   Google Scholar
• Donzé, O., and D. Picard. 2002. RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res. 30:e46.
   PubMed Web of Science ®Google Scholar
• Dutertre, M., and C. L. Smith. 2003. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen-α: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol. Endocrinol. 17:1296–1314.
   PubMedGoogle Scholar
• Endoh, H., K. Maruyama, Y. Masuhiro, Y. Kobayashi, M. Goto, H. Tai, J. Yanagisawa, D. Metzger, S. Hashimoto, and S. Kato. 1999. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor α. Mol. Cell. Biol. 19:5363–5372.
   PubMed Web of Science ®Google Scholar
• Fan, S., J. Wang, R. Yuan, Y. Ma, Q. Meng, M. R. Erdos, R. G. Pestell, F. Yuan, K. J. Auborn, I. D. Goldberg, and E. M. Rosen. 1999. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284:1354–1356.
   PubMed Web of Science ®Google Scholar
• Fernandes, I., Y. Bastien, T. Wai, K. Nygard, R. Lin, O. Cormier, H. S. Lee, F. Eng, N. R. Bertos, N. Pelletier, S. Mader, V. K. Han, X. J. Yang, and J. H. White. 2003. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 11:139–150.
   PubMed Web of Science ®Google Scholar
• Hall, J. M., J. F. Couse, and K. S. Korach. 2001. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276:36869–36872.
   PubMed Web of Science ®Google Scholar
• Hermanson, O., C. K. Glass, and M. G. Rosenfeld. 2002. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol. Metab. 13:55–60.
   PubMed Web of Science ®Google Scholar
• Ikeda, K., S. Ogawa, T. Tsukui, K. Horie-Inoue, Y. Ouchi, S. Kato, M. Muramatsu, and S. Inoue. 2004. Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription. Mol. Endocrinol. 18:1131–1143.
   PubMedGoogle Scholar
• Joel, P. B., J. Smith, T. W. Sturgill, T. L. Fisher, J. Blenis, and D. A. Lannigan. 1998. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18:1978–1984.
   PubMed Web of Science ®Google Scholar
• Joel, P. B., A. M. Traish, and D. A. Lannigan. 1995. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol. Endocrinol. 9:1041–1052.
   PubMed Web of Science ®Google Scholar
• Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, D. Metzger, and P. Chambon. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491–1494.
   PubMed Web of Science ®Google Scholar
• Kirstein, M., L. Sanz, S. Quinones, J. Moscat, M. T. Diaz-Meco, and J. Saus. 1996. Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. J. Biol. Chem. 271:18231–18236.
   PubMed Web of Science ®Google Scholar
• Komura, K., S. Hayashi, I. Makino, L. Poellinger, and H. Tanaka. 2001. Aryl hydrocarbon receptor/dioxin receptor in human monocytes and macrophages. Mol. Cell. Biochem. 226:107–118.
   PubMedGoogle Scholar
• Krstic, M. D., I. Rogatsky, K. R. Yamamoto, and M. J. Garabedian. 1997. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17:3947–3954.
   PubMed Web of Science ®Google Scholar
• Lannigan, D. A. 2003. Estrogen receptor phosphorylation. Steroids 68:1–9.
   PubMed Web of Science ®Google Scholar
• Le Goff, P., M. R. Montano, D. J. Schodin, and B. S. Katzenellenbogen. 1994. Phosphorylation of the human estrogen receptor—identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:4458–4466.
   PubMed Web of Science ®Google Scholar
• Lu, Q., H. K. Surks, H. Ebling, W. E. Baur, D. Brown, D. C. Pallas, and R. H. Karas. 2003. Regulation of estrogen receptor α-mediated transcription by a direct interaction with protein phosphatase 2A. J. Biol. Chem. 278:4639–4645.
   PubMedGoogle Scholar
• Lyngsø, C., G. Bouteiller, C. K. Damgaard, D. Ryom, S. Sanchez-Muñoz, P. L. Nørby, B. J. Bonven, and P. Jørgensen. 2000. Interaction between the transcription factor SPBP and the positive cofactor RNF4. An interplay between protein binding zinc fingers. J. Biol. Chem. 275:26144–26149.
   PubMedGoogle Scholar
• Martin, M. B., T. F. Franke, G. E. Stoica, P. Chambon, B. S. Katzenellenbogen, B. A. Stoica, M. S. McLemore, S. E. Olivo, and A. Stoica. 2000. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141:4503–4511.
   PubMed Web of Science ®Google Scholar
• Mason, G. G. F., A. M. Witte, M. L. Whitelaw, C. Antonsson, J. McGuire, A. Wilhelmsson, L. Poellinger, and J.-Å. Gustafsson. 1994. Purification of the DNA binding form of dioxin receptor. Role of the Arnt cofactor in regulation of dioxin receptor function. J. Biol. Chem. 269:4438–4449.
   PubMedGoogle Scholar
• McKenna, N. J., and B. W. O'Malley. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465–474.
   PubMed Web of Science ®Google Scholar
• Mérot, Y., R. Métivier, G. Penot, D. Manu, C. Saligaut, F. Gannon, F. Pakdel, O. Kah, and G. Flouriot. 2004. The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor α transcriptional activity depends upon the differentiation stage of the cell. J. Biol. Chem. 279:26184–26191.
   PubMedGoogle Scholar
• Métivier, R., G. Penot, R. P. Carmouche, M. R. Hubner, G. Reid, S. Denger, D. Manu, H. Brand, M. Kos, V. Benes, and F. Gannon. 2004. Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes. EMBO J. 23:3653–3666.
   PubMed Web of Science ®Google Scholar
• Moggs, J. G., and G. Orphanides. 2001. Estrogen receptors: orchestrators of pleiotropic responses. EMBO Rep. 2:775–781.
   PubMed Web of Science ®Google Scholar
• Nagy, L., and J. W. Schwabe. 2004. Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 29:317–324.
   PubMed Web of Science ®Google Scholar
• Nilsson, S., S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J. Å. Gustafsson. 2001. Mechanisms of estrogen action. Physiol. Rev. 81:1535–1565.
   PubMed Web of Science ®Google Scholar
• Ohtake, F., K. Takeyama, T. Matsumoto, H. Kitagawa, Y. Yamamoto, K. Nohara, C. Tohyama, A. Krust, J. Mimura, P. Chambon, J. Yanagisawa, Y. Fujii-Kuriyama, and S. Kato. 2003. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423:545–550.
   PubMed Web of Science ®Google Scholar
• Picard, D. 2003. SCOPE/IUPAC project on environmental implications of endocrine active substances. Molecular mechanisms of cross-talk between growth factors and nuclear receptor signaling. Pure Appl. Chem. 75:1743–1756.
   Google Scholar
• Porter, W., B. Saville, D. Hoivik, and S. Safe. 1997. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11:1569–1580.
   PubMed Web of Science ®Google Scholar
• Rajadhyaksha, A., M. Riviere, P. Van Vooren, J. Szpirer, C. Szpirer, J. Babin, and M. Bina. 1998. Assignment of AR1, transcription factor 20 (TCF20), to human chromosome 22q13.3 with somatic cell hybrids and in situ hybridization. Cytogenet. Cell Genet. 81:176–177.
   PubMedGoogle Scholar
• Reid, G., M. R. Hubner, R. Métivier, H. Brand, S. Denger, D. Manu, J. Beaudouin, J. Ellenberg, and F. Gannon. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11:695–707.
   PubMed Web of Science ®Google Scholar
• Rekdal, C., E. Sjøttem, and T. Johansen. 2000. The nuclear factor SPBP contains different functional domains and stimulates the activity of various transcriptional activators. J. Biol. Chem. 275:40288–40300.
   PubMedGoogle Scholar
• Rogatsky, I., J. M. Trowbridge, and M. J. Garabedian. 1999. Potentiation of human estrogen receptor α transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. J. Biol. Chem. 274:22296–22302.
   PubMed Web of Science ®Google Scholar
• Sanz, L., J. Moscat, and M. T. Diaz-Meco. 1995. Molecular characterization of a novel transcription factor that controls stromelysin expression. Mol. Cell. Biol. 15:3164–3170.
   PubMedGoogle Scholar
• Saville, B., H. Poukka, M. Wormke, O. A. Jänne, J. J. Palvimo, M. Stoner, I. Samudio, and S. Safe. 2002. Cooperative coactivation of estrogen receptor α in ZR-75 human breast cancer cells by SNURF and TATA-binding protein. J. Biol. Chem. 277:2485–2497.
   PubMedGoogle Scholar
• Seipel, K., O. Georgiev, and W. Schaffner. 1992. Different activation domains stimulate transcription from remote (enhancer) and proximal (promoter) positions. EMBO J. 11:4961–4968.
   PubMedGoogle Scholar
• Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar, and M. Brown. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843–852.
   PubMed Web of Science ®Google Scholar
• Steinmetz, A. C., J. P. Renaud, and D. Moras. 2001. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 30:329–359.
   PubMedGoogle Scholar
• Teyssier, C., K. Belguise, F. Galtier, and D. Chalbos. 2001. Characterization of the physical interaction between estrogen receptor α and JUN proteins. J. Biol. Chem. 276:36361–36369.
   PubMed Web of Science ®Google Scholar
• Tolón, R. M., A. I. Castillo, A. M. Jimenez-Lara, and A. Aranda. 2000. Association with Ets-1 causes ligand- and AF2-independent activation of nuclear receptors. Mol. Cell. Biol. 20:8793–8802.
   PubMedGoogle Scholar
• Tora, L., A. Mullick, D. Metzger, M. Ponglikitmongkol, I. Park, and P. Chambon. 1989. The cloned human estrogen receptor contains a mutation which alters its hormone binding properties. EMBO J. 8:1981–1986.
   PubMedGoogle Scholar
• Tora, L., J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon. 1989. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477–487.
   PubMed Web of Science ®Google Scholar
• Tremblay, A., G. B. Tremblay, F. Labrie, and V. Giguère. 1999. Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol. Cell 3:513–519.
   PubMed Web of Science ®Google Scholar
• Tzukerman, M. T., A. Esty, D. Santiso Mere, P. Danielian, M. G. Parker, R. B. Stein, J. W. Pike, and D. P. McDonnell. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:21–30.
   PubMed Web of Science ®Google Scholar
• van't Veer, L. J., H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, M. Mao, H. L. Peterse, K. van der Kooy, M. J. Marton, A. T. Witteveen, G. J. Schreiber, R. M. Kerkhoven, C. Roberts, P. S. Linsley, R. Bernards, and S. H. Friend. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536.
   PubMed Web of Science ®Google Scholar
• Wärnmark, A., E. Treuter, A. P. Wright, and J. Å. Gustafsson. 2003. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol. Endocrinol. 17:1901–1909.
   PubMedGoogle Scholar
• Wärnmark, A., A. Wikström, A. P. Wright, J. Å. Gustafsson, and T. Härd. 2001. The N-terminal regions of estrogen receptor α and β are unstructured in vitro and show different TBP binding properties. J. Biol. Chem. 276:45939–45944.
   PubMedGoogle Scholar
• Yaffe, M. B., and S. J. Smerdon. 2004. The use of in vitro peptide-library screens in the analysis of phosphoserine/threonine-binding domain structure and function. Annu. Rev. Biophys. Biomol. Struct. 33:225–244.
   PubMedGoogle Scholar